The urgent need for better treatments for Guillain-Barré Syndrome
Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.
The Free Press Journal5d
Pune: Health Officials Confirm Guillain-Barre Syndrome Outbreak Has Subsided
The Guillain-Barre Syndrome (GBS) outbreak in Pune has subsided considerably, health officials said on Wednesday, adding that there were no new hospital admissions linked to the rare neurological ...
USA Today6d
Why Florida football QB DJ Lagway started his foundation and why he's targeting women's sports
Lagway was inspired to start his foundation after the NCAA allowed student-athletes to profit off their Name, Image and Likeness in 2021. Several of Lagway's teammates showed their support by ...
pharmaphorum4d
FDA clears Argenx’ Vyvgart Hytrulo for rare disease CIDP
Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...
Bloomberg L.P.3d
Gold Bullion Securities Ltd
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
The Guardian Nigeria5d
Foundation condemns killing of teenage with Down Syndrome, demands justice
The Down Syndrome Foundation Nigeria has condemned the brutal murder of 16-year-old Ms Deborah, a girl with Down Syndrome, allegedly by her own father in Calabar, Cross River State. Apostle Ubong ...
casereports.bmj5d
Case of Guillain-Barré syndrome following COVID-19 vaccine
Guillain-Barré syndrome (GBS) is a rare immune-mediated disorder of the peripheral nerves. Although its cause is not fully understood, the syndrome often follows infection with a virus or bacteria, ...